Anti-SARS Envelope Protein (18957)
- -
- -
Antibody DetailsProduct DetailsReactivity Species Sars Host Species Rabbit Immunogen Synthetic peptide corresponding to the amino-terminus of SARS-CoV envelope protein. Product Concentration 1.0 mg/ml Formulation PBS, 0.02% sodium azide. State of Matter Liquid Product Preparation Purified by peptide immuno-affinity chromatography Storage and Handling This antibody is stable for at least one (1) year at -20°C. Country of Origin USA Shipping Next Day 2-8°C Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Rabbit Polyclonal Antibody specific to SARS Envelope Protein Background Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus
referred to as SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in
February 2003. Over the next few months, the illness spread to more than two dozen countries in
North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was
contained. SARS-CoV is transmitted from person to person by close personal contact such as
via respiratory droplets produced when an infected person coughs or sneezes. The genomes of
these viruses are positive-stranded RNA approximately 27-31kb long. The envelope (E) protein
is the smallest of the major structural SARS proteins. During virus replication, E is expressed in
the infected cell, but only a small portion of it is incorporated into the virus envelope. The majority
of E protein is found at the site of intracellular trafficking (i.e. ER, Golgi) where it plays a role in
virus assembly and budding. Antigen DetailsResearch Area Infectious Disease References & CitationsTechnical Protocols |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
